
Blog
Investing in PPD’s Early Development Services Can Help Expedite the Clinical Process
Read Full Post
Leveraging Decentralized Real-World Evidence (RWE) Data Collection Strategies During the COVID-19 Pandemic and Beyond


New and Emerging Regulatory Guidance for Cell and Gene Therapy Product Development


The Critical Need for Pregnancy Registry Studies and Robust Safety Monitoring in COVID-19 Vaccines


Predicting Extractables & Leachables Amounts using Mathematical Modeling


Overcoming Barriers to Large Global Studies: Cardiovascular Outcomes and Vaccine Trial Leaders on Research Methods That Made a Difference


Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.


Time to Act is Now: Paediatrics Medicines Development in the UK


Early Engagement Strategies to Set Cell & Gene Therapies Up for Success


Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

